Acute Myelogenous Leukemia

Partial table of contents: ETIOLOGY. Additional Observations on High Risk of Leukemia (R. Miller). Possible Relationship of Exposure to Low Energy Electromagnetic Fields and Cancer (C. Byus). MOLECULAR AND CELLULAR BIOLOGY. The Biology of Blast Cells in Acute Myeloblastic Leukemia (E. McCulloch). Analysis of Clonal Cell Populations in Human Leukemia (A. Turhan, et al.). CLINICAL ASPECTS. Cytogenetic Abnormalities in Childhood AML (D. Kalwinsky, et al.). Response to Treatment in Acute Myelogenous Leukemia (H. Preisler). CHEMOTHERAPY--CHILDREN. Evaluating Therapy for AML (A. Keating & R. Gale). AML Trials at St. Jude Children2s Research Hospital (J. Mirro, et al.). CHEMOTHERAPY--ADULTS. Effect of Exclusion Criteria on Interpretation of Clinical Outcome in AML (A. Keating & M. Baker). Survival with Acute Myelogenous Leukemia (A. Rohatiner, et al.). TRANSPLANTS. Strategies to Treat Acute Myelogenous Leukemia (R. Gale & A. Butturini). Bone Marrow Transplantation for AML in Europe (A. Gratwohl, et al.). NEW THERAPIES. Use of CSFs in AML (E. Estey, et al.). SUMMARY. Acute Myelogenous Leukemia: Progress and Controversies (R. Gale).Gale, Robert P. is the author of 'Acute Myelogenous Leukemia', published 1990 under ISBN 9780471568728 and ISBN 0471568724.